PRIMAEGISresearch
← Screener
ASTEC

AstecLifesciences

Agrochemicals/ 1 document · covered since May 2026
Latest view
Constructive
as of 29 May 2026 · not a recommendation

Evidence timeline

What management said

from NSE earnings-call filings · extracted, not interpreted
Call 01-Nov-2022 · transcript PDF

Outlook, as stated

For example, in the coming year FY2023, we have committed almost Rs.350 Crores to Rs.400 Crores capex and depending on how we proceed over the next two to three years, we will continue to invest depending on the pipeline generation and the R&D capability which we will be building in the near short term.

Anurag Roy: So, I mentioned Rs.35 Crores to Rs.50 Crores commitment for the plant capacity expansion and again, you could take two to three years for full utilization for the new capacities and accordingly, obviously there will be some uptick in the revenues from this new herbicide investment as well.

We have a very healthy pipeline of products coming into the herbicide plant and we expect to take it to almost 90% to 100% utilization in year three so as we get on to FY2023 we are expecting to take the utilization rates to almost 70%.

4.11 concrete references per 100 words spoken — counts, currency, units and named periods, not adjectives

Chart exhibits

as drawn · not updated since

No forward scenario

the call carried no figure that bridges to earnings growth.

Price chart

260 sessions to 31 Jul 2026 · daily close · our own broker data
600 800 Jul Sep Nov 2026 Mar May Jul vol 655.35
14 Jul 2025 → 31 Jul 2026 low ₹521.85 · high ₹930.3 · last ₹655.35 · -29.6% over the window close 50-DMA 200-DMA